Log In
BCIQ
Print this Print this
 

MoviPrep (NRL944)

  Manage Alerts
Collapse Summary General Information
Company Norgine B.V.
DescriptionLiquid polyethylene glycol (PEG) purgative
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationConstipation
Indication DetailsCleanse bowel prior to colonoscopy; Cleanse bowel prior to colonoscopy, intestinal surgery and other situations where a clean bowel is required
Regulatory Designation
PartnerAcino International AG;
Ajinomoto Co. Inc.;
Takeda Pharmaceutical Co. Ltd.;
Valeant Pharmaceuticals International Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

$12,561.7M

$11,726.7M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today